Company · CIK 0001626971 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Corvus Pharmaceuticals, Inc. · CRVS
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 11, 2026 PForm 4 → | Jun 15, 5:12 pm EDT | David Scott MooreDirector | 21,700 | $11.53 | $250,236 | 21,700 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 11, 2026 AForm 4 → | Jun 15, 5:12 pm EDT | David Scott MooreDirector | 15,000 | — | — | 15,000 | — | |
| Jun 11, 2026 AForm 4 → | Jun 15, 5:10 pm EDT | Ian T ClarkDirector | 15,000 | — | — | 15,000 | — | |
| Jun 11, 2026 AForm 4 → | Jun 15, 5:08 pm EDT | Linda GraisDirector | 15,000 | — | — | 15,000 | — | |
| Jun 11, 2026 AForm 4 → | Jun 15, 5:06 pm EDT | Peter A. ThompsonDirector, 10% Owner | 15,000 | — | — | 15,000 | — | |
| Jun 11, 2026 AForm 4 → | Jun 15, 5:04 pm EDT | Richard van den BroekDirector | 15,000 | — | — | 15,000 | — |